These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19860681)

  • 1. HLA-G molecule.
    Kamishikiryo J; Maenaka K
    Curr Pharm Des; 2009; 15(28):3318-24. PubMed ID: 19860681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
    Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.
    Apps R; Gardner L; Sharkey AM; Holmes N; Moffett A
    Eur J Immunol; 2007 Jul; 37(7):1924-37. PubMed ID: 17549736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune modulation of HLA-G dimer in maternal-fetal interface.
    Kuroki K; Maenaka K
    Eur J Immunol; 2007 Jul; 37(7):1727-9. PubMed ID: 17587197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrameric complexes of HLA-E, HLA-F, and HLA-G.
    Allan DS; Lepin EJ; Braud VM; O'Callaghan CA; McMichael AJ
    J Immunol Methods; 2002 Oct; 268(1):43-50. PubMed ID: 12213342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.
    Lepin EJ; Bastin JM; Allan DS; Roncador G; Braud VM; Mason DY; van der Merwe PA; McMichael AJ; Bell JI; Powis SH; O'Callaghan CA
    Eur J Immunol; 2000 Dec; 30(12):3552-61. PubMed ID: 11169396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA-G: an immunoregulatory non classical class I HLA molecule].
    Ksouri H; Bardi R; Mellouli F; Bejaoui M
    Arch Inst Pasteur Tunis; 2009; 86(1-4):27-38. PubMed ID: 20707218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerization of dendritic cells by HLA-G.
    Ristich V; Liang S; Zhang W; Wu J; Horuzsko A
    Eur J Immunol; 2005 Apr; 35(4):1133-42. PubMed ID: 15770701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-G and immune tolerance in pregnancy.
    Hunt JS; Petroff MG; McIntire RH; Ober C
    FASEB J; 2005 May; 19(7):681-93. PubMed ID: 15857883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance.
    Wu J; Zhang W; Hernandez-Lopez P; Fabelo E; Parikh M; Mulloy LL; Horuzsko A
    Hum Immunol; 2009 Dec; 70(12):988-94. PubMed ID: 19664670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubal versus uterine placentation: similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment.
    Pröll J; Bensussan A; Goffin F; Foidart JM; Berrebi A; Le Bouteiller P
    Tissue Antigens; 2000 Dec; 56(6):479-91. PubMed ID: 11169237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization and preliminary X-ray analysis of the low-affinity complex between human leukocyte antigen-G (HLA-G) and leukocyte Ig-like receptor B2 (LILRB2).
    Shiroishi M; Maenaka K
    Protein Pept Lett; 2009; 16(4):447-9. PubMed ID: 19356145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords.
    McIntire RH; Sifers T; Platt JS; Ganacias KG; Langat DK; Hunt JS
    Placenta; 2008 Jul; 29(7):631-8. PubMed ID: 18538388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the increasing complexity of the immunomodulatory HLA-G molecule.
    Carosella ED; Favier B; Rouas-Freiss N; Moreau P; Lemaoult J
    Blood; 2008 May; 111(10):4862-70. PubMed ID: 18334671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid production of human KIR2DL4 extracellular domain and verification of its interaction with HLA-G.
    Yu YR; Tian XH; Wang Y; Feng MF
    Biochemistry (Mosc); 2006; 71 Suppl 1():S60-4, 4-5. PubMed ID: 16487070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.
    Ryu M; Chen Y; Qi J; Liu J; Fan Z; Nam G; Shi Y; Cheng H; Gao GF
    PLoS One; 2011 Apr; 6(4):e19245. PubMed ID: 21559424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
    Morel E; Bellón T
    J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.